KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Zimmer Biomet Holdings (ZBH) Gross Profit (2016 - 2025)

Zimmer Biomet Holdings has reported Gross Profit over the past 17 years, most recently at $1.5 billion for Q4 2025.

  • Quarterly results put Gross Profit at $1.5 billion for Q4 2025, up 1.04% from a year ago — trailing twelve months through Dec 2025 was $5.7 billion (up 4.57% YoY), and the annual figure for FY2025 was $5.7 billion, up 4.56%.
  • Gross Profit for Q4 2025 was $1.5 billion at Zimmer Biomet Holdings, up from $1.4 billion in the prior quarter.
  • Over the last five years, Gross Profit for ZBH hit a ceiling of $1.5 billion in Q2 2025 and a floor of $1.2 billion in Q1 2022.
  • Median Gross Profit over the past 5 years was $1.3 billion (2022), compared with a mean of $1.3 billion.
  • Peak annual rise in Gross Profit hit 58.07% in 2021, while the deepest fall reached 28.78% in 2021.
  • Zimmer Biomet Holdings' Gross Profit stood at $1.2 billion in 2021, then rose by 5.17% to $1.3 billion in 2022, then increased by 7.4% to $1.4 billion in 2023, then increased by 2.51% to $1.4 billion in 2024, then rose by 1.04% to $1.5 billion in 2025.
  • The last three reported values for Gross Profit were $1.5 billion (Q4 2025), $1.4 billion (Q3 2025), and $1.5 billion (Q2 2025) per Business Quant data.